---
title: "Embecta Corp. 3Q 2026: Revenue $221.8M, EPS $(0.07) — 10-Q Summary"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285245716.md"
description: "Embecta Corp. reported Q3 2026 results with revenue of $221.8M, down 14.4% YoY, and a net loss of $4.1M, resulting in a diluted EPS of $(0.07). This contrasts with the previous year's revenue of $259M and net income of $23.5M. The decline was attributed to volume decreases and pricing pressures. The company is facing challenges from commoditization and competitive pricing, while also managing raw material supply disruptions. Operational actions include acquiring Owen Mumford and launching a $100M share repurchase program."
datetime: "2026-05-05T17:41:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285245716.md)
  - [en](https://longbridge.com/en/news/285245716.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285245716.md)
---

# Embecta Corp. 3Q 2026: Revenue $221.8M, EPS $(0.07) — 10-Q Summary

Embecta Corp. reported third-quarter 2026 results with revenue of $221.8M and a consolidated net loss of $4.1M, or diluted loss per share of $(0.07), compared with revenue of $259M, net income of $23.5M and diluted EPS of $0.4 in the year‑ago quarter.

**Financial Highlights**

-   Revenue: $221.8M for Q3 2026 (three months ended Mar 31, 2026), down from $259.0M in the year‑ago quarter (−14.4% YoY).
-   Net income: $(4.1) M for Q3 2026 (consolidated net loss), versus $23.5M net income in the year‑ago quarter.
-   Diluted EPS: $(0.07) for Q3 2026, versus $0.40 in the year‑ago quarter.

**Business Highlights**

-   Revenue declines of roughly 14% quarter‑over‑quarter and about 7% year‑to‑date were driven primarily by volume decreases and pricing pressure in key markets.
-   Channel and product mix shifts, including modestly reduced contract manufacturing revenues, weighed on top‑line performance and supply dynamics.
-   Company faces commoditization and increased competitive and payor pricing pressure; noted risks from brand transition and global trade/tariff exposure.
-   Operational actions include entering a definitive agreement to acquire Owen Mumford, launching a cost‑structure review and approving a $100M share repurchase program.
-   Managed raw material supply disruptions by increasing inventories to maintain uninterrupted customer supply.

Original SEC Filing: Embecta Corp. \[ EMBC \] - 10-Q - May. 05, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [EMBC.US](https://longbridge.com/en/quote/EMBC.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)

## Related News & Research

- [Edwards Lifesciences CVP, Strategy/Corp Development Sold Shares Worth Over $1.4M](https://longbridge.com/en/news/286822028.md)
- [Lifeward Delays Quarterly Report Amid Deal Accounting](https://longbridge.com/en/news/286586728.md)
- [ONWARD Medical to Announce First Quarter 2026 Results on May 26, 2026 | ONWRY Stock News](https://longbridge.com/en/news/286858298.md)
- [GE Vernova Declares Third Quarter 2026 Dividend | GEV Stock News](https://longbridge.com/en/news/286966387.md)
- [embecta Completes Acquisition of Owen Mumford Holdings Limited](https://longbridge.com/en/news/286571686.md)